Clinical Trial Update: A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2 clinical trial evaluating GenSci134 in children with idiopathic short stature; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Drugs mentioned

• GenSci134

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Idiopathic Short Stature | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING